Sermorelin vs. HGH: Key Differences

Recombinant HGH: Direct Supplementation

Recombinant human growth hormone is a synthetically produced version of the growth hormone molecule, identical in structure to the GH secreted by the pituitary gland. When injected, it adds GH directly to the bloodstream, bypassing the body's regulatory feedback mechanisms entirely. The pituitary does not need to produce anything. Because rHGH bypasses the pituitary's feedback regulation, the risk of elevated IGF-1 levels and associated side effects — insulin resistance, fluid retention, carpal tunnel syndrome, and joint pain — is higher than with secretagogue-based approaches. rHGH is also significantly more expensive, often costing several hundred to over a thousand dollars per month.

Sermorelin: Stimulating the Body's Own Production

Sermorelin stimulates the pituitary to generate its own GH pulse. The critical distinction: this process remains under the body's normal feedback control. Somatostatin — the hormone that inhibits GH release when levels are already adequate — continues to function as a check on the system. The result is a physiologically regulated increase in GH secretion rather than potentially supraphysiologic external supplementation. Because sermorelin stimulates the pituitary rather than replacing its function, the pituitary gland is kept active and responsive rather than experiencing the downregulation that can occur with prolonged direct GH use. Sermorelin therapy typically costs significantly less than rHGH.

These therapies are offered as part of individualized wellness programs and are not intended to diagnose, treat, cure, or prevent any disease. They are not a replacement for proper medical evaluation, imaging, rehabilitation, or other medically indicated care. Consult your provider to determine whether these wellness options are appropriate for your situation.